Citadel Advisors - STRONGBRIDGE BIOPHARMA PLC ownership

STRONGBRIDGE BIOPHARMA PLC's ticker is SBBP and the CUSIP is G85347105. A total of 64 filers reported holding STRONGBRIDGE BIOPHARMA PLC in Q2 2018. The put-call ratio across all filers is - and the average weighting 0.5%.

Quarter-by-quarter ownership
Citadel Advisors ownership history of STRONGBRIDGE BIOPHARMA PLC
ValueSharesWeighting
Q2 2021$153,000
-37.3%
51,599
-41.5%
0.00%
Q1 2021$244,000
+117.9%
88,165
+91.3%
0.00%
Q4 2020$112,000
+69.7%
46,078
+44.9%
0.00%
Q3 2020$66,000
-65.8%
31,800
-37.3%
0.00%
Q2 2020$193,000
-17.9%
50,721
-59.2%
0.00%
Q1 2020$235,000
+658.1%
124,284
+722.4%
0.00%
Q4 2019$31,000
-80.3%
15,113
-53.3%
0.00%
Q3 2018$157,000
-5.4%
32,348
+71.9%
0.00%
Q1 2018$166,00018,8130.00%
Other shareholders
STRONGBRIDGE BIOPHARMA PLC shareholders Q2 2018
NameSharesValueWeighting ↓
CAXTON CORP 6,612,065$12,497,00013.66%
Ikarian Capital, LLC 3,392,787$6,412,0000.48%
NEA Management Company, LLC 4,141,308$7,827,0000.41%
Alambic Investment Management, L.P. 61,764$117,0000.28%
KNOTT DAVID M 181,800$344,0000.22%
683 Capital Management, LLC 917,942$1,736,0000.10%
Hudson Bay Capital Management LP 1,409,419$2,664,0000.07%
BOOTHBAY FUND MANAGEMENT, LLC 388,309$734,0000.06%
&PARTNERS 15,000$28,0000.04%
Diversified Trust Co 198,534$375,0000.02%
View complete list of STRONGBRIDGE BIOPHARMA PLC shareholders